MC
TMO icon

Miramar Capital’s Thermo Fisher Scientific TMO Stock Holding History

Miramar Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-347
Closed -$201K – 60
2025
Q4 		$201K Buy
+347
New +$196K 0.04% 55
2023
Q3 		– Sell
-490
Closed -$256K – 77
2023
Q2 		$256K Sell
490
-35
-7% -$18.9K 0.06% 63
2023
Q1 		$303K Sell
525
-110
-17% -$62K 0.08% 65
2022
Q4 		$350K Buy
635
+35
+6% +$18.5K 0.09% 65
2022
Q3 		$291K Sell
600
-217
-27% -$121K 0.08% 74
2022
Q2 		$444K Sell
817
-35
-4% -$19.3K 0.13% 66
2022
Q1 		$503K Buy
+852
New +$489K 0.14% 73

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Miramar Capital's TMO Position: Q1 2026 in Review

Miramar Capital sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 347 shares — an estimated $201K sold.

Miramar Capital first reported a position in TMO in Q1 2022 and held it in 7 quarters. The position peaked at $503K in Q1 2022. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Miramar Capital reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
  • Miramar Capital sold 347 Thermo Fisher Scientific shares in Q1 2026, an estimated $201K.
  • Miramar Capital first reported a position in Thermo Fisher Scientific in Q1 2022 and held it in 7 quarters.
  • Miramar Capital's Thermo Fisher Scientific position peaked at $503K in Q1 2022.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Miramar Capital's 13F filing for Q1 2026, filed 11 May 2026.